Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Allurion Technologies Inc.
OTC:ALUROTC (delisted from NYSE, Form 25 effective Oct 23, 2026)Healthcare · Medical - Devices